IonQ is preparing for its annual investor day on September 8, with analysts expecting the company’s $1.8 billion SkyWater Technology acquisition to be the main focus.

IonQ stock opened at $37.87 on Wednesday, well below the analyst average price target of $69.92. The shares have traded in a 12-month range of $25.89 to $84.64, and the company has a market capitalization of $14.43 billion.

The investor day is shaping up to be one of the most closely watched events in the quantum computing sector. StoneX analyst Gary Mobley said IonQ’s dealmaking is the key story. The SkyWater deal, which closed in late July, is IonQ’s largest acquisition to date and gives the company control of its own chip foundry.

With the acquisition, IonQ can now provide semiconductor fabrication, chip design, and advanced packaging to other companies. That marks a significant shift for a business that began as a pure-play quantum computing company and helps explain why investors are likely to focus on how management plans to integrate the business into its broader technology stack.

Mobley said the SkyWater acquisition could accelerate IonQ’s roadmap for a 200,000-qubit system by about a year. He linked that timeline to a recent executive order calling for a fault-tolerant quantum computer at a national lab by 2028.

SkyWater Deal Brings Financial Complexity

The financial impact of the acquisition is not straightforward. Because IonQ was already a major SkyWater customer, analysts cannot simply add SkyWater’s revenue to IonQ’s top line. Mobley said investors should reduce SkyWater’s revenue contribution by about 20% to account for canceled internal transactions.

IonQ had been on track to pay SkyWater $120 million in 2026, including $80 million in the second half of the year. Current consensus estimates do not yet reflect the full SkyWater effect, which means the investor day is likely to be an important checkpoint for updated disclosure rather than just a strategy presentation.

Mobley also expects the transaction to compress combined profit margins and add about $93 million in operating expenses this year. IonQ is expected to provide full guidance on the deal’s financial impact at the September 8 event.

IonQ’s second-quarter results gave investors a recent update on the company’s operating performance. Revenue reached $80.05 million, up 286.7% from a year earlier and ahead of analyst expectations of $66.47 million. Adjusted loss per share was $0.33, better than the $0.56 analysts had projected.

New Drug Discovery Work Adds Another Angle

IonQ also had a new development this week to highlight before investor day. The company and QC Ware demonstrated a hybrid quantum-classical chemistry workflow using IonQ’s Forte system through Amazon Braket.

The test produced enzyme interaction-energy results within 4% of a benchmark, meeting the chemical-accuracy threshold cited for pharmaceutical research. The work points to a possible role in drug discovery, an area beyond IonQ’s traditional focus and one that could broaden how the company frames practical applications for its platform.

CEO Niccolo de Masi has been clear about the company’s long-term ambition. “Our ambition is always to be the Nvidia of quantum,” he told Barron’s after the last earnings call.

Analyst sentiment remains broadly positive. Nine analysts currently rate IonQ a Buy, four rate it Hold, and one rates it Sell, giving the stock a consensus rating of “Moderate Buy.”

IonQ’s public warrants are set to expire on September 30. If exercised, they could increase the share count and create near-term dilution pressure on the stock.

The combination of the SkyWater acquisition, the upcoming investor day, the recent quarterly results, and the warrant expiration makes this a closely watched period for IonQ and its shareholders, with investors likely looking for more detail on execution, integration, and capital structure in the weeks ahead.